SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,957,000 | +264.8% | 104,851 | +380.7% | 0.01% | +250.0% |
| Q1 2021 | $1,633,000 | -54.9% | 21,814 | -47.9% | 0.00% | -55.6% |
| Q4 2020 | $3,619,000 | -59.9% | 41,830 | -71.7% | 0.01% | -65.4% |
| Q3 2020 | $9,019,000 | +1207.1% | 147,568 | +514.9% | 0.03% | +1200.0% |
| Q1 2020 | $690,000 | -36.3% | 24,000 | +60.0% | 0.00% | -50.0% |
| Q4 2019 | $1,083,000 | +2.9% | 15,000 | +100.0% | 0.00% | 0.0% |
| Q3 2019 | $1,052,000 | -17.9% | 7,500 | +7.1% | 0.00% | -20.0% |
| Q2 2019 | $1,282,000 | +34.4% | 7,000 | +16.7% | 0.01% | +25.0% |
| Q1 2019 | $954,000 | -66.2% | 6,000 | -70.0% | 0.00% | -63.6% |
| Q3 2018 | $2,823,000 | -23.1% | 19,989 | -14.8% | 0.01% | -26.7% |
| Q2 2018 | $3,672,000 | +18.8% | 23,460 | +22.3% | 0.02% | +7.1% |
| Q1 2018 | $3,090,000 | +188.5% | 19,184 | +195.1% | 0.01% | +180.0% |
| Q4 2017 | $1,071,000 | +71.6% | 6,500 | -35.1% | 0.01% | +66.7% |
| Q3 2017 | $624,000 | -13.0% | 10,009 | +11.1% | 0.00% | 0.0% |
| Q2 2017 | $717,000 | +26.0% | 9,009 | +12.6% | 0.00% | 0.0% |
| Q1 2017 | $569,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |